Cargando…

Brazilian Landscape of Hepatocellular Carcinoma

The incidence of hepatocellular carcinoma (HCC) is expected to increase in the coming years, and strategies to mitigate the burden of this disease are needed in different regions. Geographic variations in epidemiology and risk factors, such as viral hepatitis and metabolic disease, pose challenges i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fonseca, Leonardo G., Chen, Andre T.C., de Oliveira, Irai S., Chagas, Aline L., Kruger, Jaime A.P., Carrilho, Flair J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2023
Materias:	REVIEW ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497258/ https://www.ncbi.nlm.nih.gov/pubmed/37348031 http://dx.doi.org/10.1200/GO.22.00416

Ejemplares similares

Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2018)

Hepatocellular carcinoma (HCC) in patients with Non-Alcoholic Fatty Liver Disease (NAFLD): screening, treatment and survival analysis in a Brazilian series
por: Alencar, Regiane Saraiva de Souza Melo, et al.
Publicado: (2022)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey
por: Cotrim, Helma P., et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
por: Kikuchi, Luciana, et al.
Publicado: (2014)

Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment
por: Da Fonseca, Leonardo G., et al.
Publicado: (2023)

Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics
por: Da Fonseca, Leonardo G, et al.
Publicado: (2023)

Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage
por: Kikuchi, Luciana, et al.
Publicado: (2017)

A multidisciplinary approach to peritoneal metastasis from hepatocellular carcinoma: clinical features, management and outcomes
por: Da Fonseca, Leonardo G., et al.
Publicado: (2022)

Methylene tetrahydrofolate reductase (MTHFR) and vascular endothelial growth factor (VEGF) polymorphisms in Brazilian patients with Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC)
por: Carvalho, Sylene C.R., et al.
Publicado: (2021)

Hepatocellular carcinoma recurrence after liver transplantation in a Brazilian multicenter study: clinical profile and prognostic factors of survival
por: Chagas, Aline L., et al.
Publicado: (2019)

Hepatocellular Carcinoma Related to Schistosoma mansoni Infection: Case Series and Literature Review
por: Toda, Karla Sawada, et al.
Publicado: (2015)

Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil
por: Carrilho, Flair Jose, et al.
Publicado: (2010)

Feasibility of SBRT for hepatocellular carcinoma in Brazil — a prospective pilot study
por: Chen, Andre Tsin Chih, et al.
Publicado: (2021)

Is hepatic venous pressure gradient assessment required before liver resection in patients with cirrhosis and hepatocellular carcinoma?
por: Silva, Mauricio F., et al.
Publicado: (2013)

Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases
por: Chagas, Aline Lopes, et al.
Publicado: (2015)

Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System
por: Kikuchi, Luciana, et al.
Publicado: (2016)

Epidemiological and Clinical Patterns of Newly Diagnosed Hepatocellular Carcinoma in Brazil: the Need for Liver Disease Screening Programs Based on Real-World Data
por: Fernandes, Gustavo dos Santos, et al.
Publicado: (2020)

Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence
por: Da Fonseca, Leonardo G., et al.
Publicado: (2022)

Management of Hepatocellular Carcinoma during the COVID-19 Pandemic - São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement
por: Chagas, Aline Lopes, et al.
Publicado: (2020)

Association of LEC and tnpA Helicobacter pylori genes with gastric cancer in a Brazilian population
por: Mattar, Rejane, et al.
Publicado: (2010)

Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and high plasma homocysteine in chronic hepatitis C (CHC) infected patients from the Northeast of Brazil
por: Siqueira, Erika RF, et al.
Publicado: (2011)

Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography–mass spectrometry
por: Passos-Castilho, Ana Maria, et al.
Publicado: (2015)

Analysis of HFE And Non-HFE Gene Mutations in Brazilian Patients with Hemochromatosis
por: Bittencourt, Paulo Lisboa, et al.
Publicado: (2009)

Caves as wildlife refuges in degraded landscapes in the Brazilian Amazon
por: de Fraga, Rafael, et al.
Publicado: (2023)

INFLUENCE OF HEPATOCELLULAR CARCINOMA ETIOLOGY IN THE SURVIVAL AFTER RESECTION
por: LOPES, Felipe de Lucena Moreira, et al.
Publicado: (2016)

LCT‐22018G>A single nucleotide polymorphism is a better predictor of adult‐type hypolactasia/lactase persistence in Japanese‐Brazilians than LCT‐13910C>T
por: Mattar, Rejane, et al.
Publicado: (2010)

Frequency of LCT -13910C>T single nucleotide polymorphism associated with adult-type hypolactasia/lactase persistence among Brazilians of different ethnic groups
por: Mattar, Rejane, et al.
Publicado: (2009)

The mutational landscape of hepatocellular carcinoma
por: Lee, Ju-Seog
Publicado: (2015)

The fusion landscape of hepatocellular carcinoma
por: Zhu, Chengpei, et al.
Publicado: (2019)

The genomic landscape of Mongolian hepatocellular carcinoma
por: Candia, Julián, et al.
Publicado: (2020)

Characterization of metabolic landscape in hepatocellular carcinoma
por: Wu, Jing, et al.
Publicado: (2021)

Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: Brazilian Survey
por: Alves, Venancio Avancini Ferreira, et al.
Publicado: (2016)

Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion
por: Kulik, Laura, et al.
Publicado: (2020)

PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings
por: Leathers, James S, et al.
Publicado: (2018)

The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We?
por: Hu, Xin, et al.
Publicado: (2022)

New landscapes and horizons in hepatocellular carcinoma therapy
por: Cervello, Melchiorre, et al.
Publicado: (2020)

Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies
por: Giraud, Julie, et al.
Publicado: (2021)

The immune landscape of hepatocellular carcinoma-where we are?
por: Gryziak, Maciej, et al.
Publicado: (2022)

Mutational Landscape and Precision Medicine in Hepatocellular Carcinoma
por: Gorji, Leva, et al.
Publicado: (2023)

Clinical spectrum and therapeutic approach to hepatocellular injury in patients with hyperthyroidism
por: de Campos Mazo, Daniel Ferraz, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1f3f8i9fjggkho2a8rr3qnbcl7